WO2012118321A3 - Placenta extract and method for manufacturing same - Google Patents

Placenta extract and method for manufacturing same Download PDF

Info

Publication number
WO2012118321A3
WO2012118321A3 PCT/KR2012/001494 KR2012001494W WO2012118321A3 WO 2012118321 A3 WO2012118321 A3 WO 2012118321A3 KR 2012001494 W KR2012001494 W KR 2012001494W WO 2012118321 A3 WO2012118321 A3 WO 2012118321A3
Authority
WO
WIPO (PCT)
Prior art keywords
placenta extract
virus
manufacturing same
manufacturing
present
Prior art date
Application number
PCT/KR2012/001494
Other languages
French (fr)
Korean (ko)
Other versions
WO2012118321A2 (en
Inventor
한규범
유용선
임미형
Original Assignee
(주)차바이오앤디오스텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)차바이오앤디오스텍 filed Critical (주)차바이오앤디오스텍
Priority to JP2013556547A priority Critical patent/JP2014506921A/en
Priority to CN201280010127.0A priority patent/CN103533944A/en
Publication of WO2012118321A2 publication Critical patent/WO2012118321A2/en
Publication of WO2012118321A3 publication Critical patent/WO2012118321A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a placenta extract and a method for safely and effectively manufacturing the same. More particularly, the method for manufacturing the placenta extract of the present invention, includes at least one step selected from the group consisting of: a step of inactivating a virus using a surface active agent and a solvent; a step of irradiating ultraviolet rays to inactivate the virus; and a step of removing the virus using a nano filter. The thus-obtained placenta extract may be used for preventing and treating menopausal disorder symptoms in mammals.
PCT/KR2012/001494 2011-02-28 2012-02-28 Placenta extract and method for manufacturing same WO2012118321A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2013556547A JP2014506921A (en) 2011-02-28 2012-02-28 Placenta extract and method for producing the same
CN201280010127.0A CN103533944A (en) 2011-02-28 2012-02-28 Placenta extract and method for manufacturing same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110017995A KR20120098202A (en) 2011-02-28 2011-02-28 Placenta extract and process for producing the same
KR10-2011-0017995 2011-02-28

Publications (2)

Publication Number Publication Date
WO2012118321A2 WO2012118321A2 (en) 2012-09-07
WO2012118321A3 true WO2012118321A3 (en) 2012-12-20

Family

ID=46758372

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/001494 WO2012118321A2 (en) 2011-02-28 2012-02-28 Placenta extract and method for manufacturing same

Country Status (4)

Country Link
JP (1) JP2014506921A (en)
KR (1) KR20120098202A (en)
CN (1) CN103533944A (en)
WO (1) WO2012118321A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2710015C1 (en) * 2019-03-29 2019-12-24 Инна Анатольевна Аполихина Method of treating genitourinary syndrome in menopausal women by means of placental therapy
IT202200003230A1 (en) * 2022-02-22 2023-08-22 Bruno Silvestrini Sublingual pharmaceutical composition as antiviral vaccine.

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1661914A1 (en) * 2004-11-18 2006-05-31 Ortho-Clinical Diagnostics, Inc. Optimal placement of a robust solvent/detergent process post viral ultrafiltration of an immune gamma globulin
KR100642080B1 (en) * 2006-02-11 2006-11-13 케이에이취팜 주식회사 A food composition containing swine placenta extraction for improving menopausal disorder, health foods comprising of it and preparation method thereof
KR100932183B1 (en) * 2008-10-22 2009-12-16 주식회사 한국천연물사이언스 Extraction Method of Horse Placenta and Food Composition Using the Same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096872A (en) * 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
CA2394797A1 (en) * 1999-12-20 2001-06-28 Tsuyoshi Takahashi Process for producing virus-free plasma protein composition by porous membrane treatment, virus-free plasma protein composition and method of removing viruses
JP2002020299A (en) * 2000-07-04 2002-01-23 Fine Chemical Laboratory Co Ltd Placenta-containing sublingual tablet
ES2549161T3 (en) * 2001-02-14 2015-10-23 Anthrogenesis Corporation Postpartum mammalian placenta, its use and placental stem cells thereof
WO2006003926A1 (en) * 2004-06-30 2006-01-12 Terumo Kabushiki Kaisha Virus-inactivated hemoglobin and method of producing the same
JP2006158214A (en) * 2004-12-02 2006-06-22 Happy Shoji Kk Placental extract powder-formulated food
JP2007106760A (en) * 2005-09-16 2007-04-26 Kenji Yoshida Hematopoietic stem cell proliferator
CN101721458B (en) * 2009-10-30 2012-02-15 葛龙海 Method for preparing human placenta tissue fluid

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1661914A1 (en) * 2004-11-18 2006-05-31 Ortho-Clinical Diagnostics, Inc. Optimal placement of a robust solvent/detergent process post viral ultrafiltration of an immune gamma globulin
KR100642080B1 (en) * 2006-02-11 2006-11-13 케이에이취팜 주식회사 A food composition containing swine placenta extraction for improving menopausal disorder, health foods comprising of it and preparation method thereof
KR100932183B1 (en) * 2008-10-22 2009-12-16 주식회사 한국천연물사이언스 Extraction Method of Horse Placenta and Food Composition Using the Same

Also Published As

Publication number Publication date
WO2012118321A2 (en) 2012-09-07
CN103533944A (en) 2014-01-22
KR20120098202A (en) 2012-09-05
JP2014506921A (en) 2014-03-20

Similar Documents

Publication Publication Date Title
WO2013177594A3 (en) Xylitol-based anti-mucosal compositions and related methods and compositions
HK1198426A1 (en) Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism
WO2014089241A3 (en) Molecular profiling for cancer
SG195383A1 (en) Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
WO2012072713A3 (en) Lysine demethylase inhibitors such as cyclylcyclopropanamine derivatives for use in the treatment of diseases and disorders associated with flaviviridae
EP2707540A4 (en) Process for treating microfibrillated cellulose and microfibrillated cellulose treated according to the process
WO2013173506A3 (en) Kinase inhibitors for use in the treatment of muscular degradation
EA201692036A3 (en) METHOD FOR TREATING LINE-CELLULOSE MATERIALS BY ELECTRON RADIATION
WO2009114513A3 (en) Ultraviolet irradiation to treat corneal weakness disorders
MD20140035A2 (en) Method for treating hepatitis C virus
MX2014015842A (en) Purification of virus like particles.
MD20150062A2 (en) Antiviral compounds
WO2009102817A3 (en) Methods for removing dissolved metallic ions from aqueous solutions
WO2016187217A3 (en) Methods and compositions for treating aging-associated impairments
MX2022016339A (en) Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack.
WO2012044662A3 (en) Filter structure for removing contaminants from stream of fluid
WO2011110467A3 (en) System for removing contaminant particles, lithographic apparatus, method for removing contaminant particles and method for manufacturing a device
WO2006089681A3 (en) Method for increasing the laser damage threshold of diffraction grids
WO2010109330A3 (en) Cholesterol level lowering liposomes
BR112014012729A2 (en) coke wastewater treatment process
GB201108860D0 (en) Tobacco treatment
WO2010032011A3 (en) Anti-fungal therapy
WO2008112647A3 (en) Nitroxide radical as a treatment for neurodegeneration
MX2017004828A (en) Ophthalmic composition comprising cyclosporine and trehalose.
WO2011084350A3 (en) Method for treating spent regeneration gas

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12752102

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2013556547

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12752102

Country of ref document: EP

Kind code of ref document: A2